SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 45 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,535,142 | +5.2% | 8,197,000 | +0.5% | 0.95% | +11.6% |
Q2 2023 | $13,813,847 | +0.1% | 8,157,000 | +14.8% | 0.86% | -6.1% |
Q1 2023 | $13,798,218 | +55.6% | 7,106,000 | +49.7% | 0.91% | +81.5% |
Q4 2022 | $8,868,606 | +1251.9% | 4,747,000 | +849.4% | 0.50% | +1991.7% |
Q1 2022 | $656,000 | -10.5% | 500,000 | 0.0% | 0.02% | -7.7% |
Q4 2021 | $733,000 | -97.8% | 500,000 | -96.3% | 0.03% | -98.0% |
Q4 2020 | $33,505,000 | +2099.9% | 13,674,000 | +1760.4% | 1.28% | +1683.3% |
Q3 2020 | $1,523,000 | -84.0% | 735,000 | -82.3% | 0.07% | -86.7% |
Q2 2020 | $9,531,000 | +179.1% | 4,144,000 | +85.4% | 0.54% | +100.7% |
Q1 2020 | $3,415,000 | -56.7% | 2,235,000 | -44.9% | 0.27% | -38.4% |
Q4 2019 | $7,893,000 | +318.9% | 4,054,000 | +183.9% | 0.44% | +261.2% |
Q3 2019 | $1,884,000 | -92.9% | 1,428,000 | -88.0% | 0.12% | -92.1% |
Q2 2019 | $26,504,000 | -13.3% | 11,928,000 | -29.5% | 1.52% | -16.9% |
Q1 2019 | $30,560,000 | – | 16,928,000 | – | 1.83% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DLD Asset Management, LP | 10,370,000 | $18,432,675 | 1.98% |
Worth Venture Partners, LLC | 1,431,000 | $2,536,677 | 1.50% |
CSS LLC/IL | 8,197,000 | $14,535,142 | 0.95% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,198,000 | $9,252,647 | 0.20% |
Warberg Asset Management LLC | 517,000 | $911,580 | 0.18% |
BOOTHBAY FUND MANAGEMENT, LLC | 3,889,000 | $6,893,877 | 0.16% |
PALISADE CAPITAL MANAGEMENT, LP | 1,000,000 | $1,765,625 | 0.05% |
Point72 Asset Management, L.P. | 9,007,000 | $15,925,009 | 0.05% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,082,000 | $8,984,976 | 0.04% |
D. E. Shaw & Co., Inc. | 11,089,000 | $19,645,113 | 0.02% |